Market Overview The tetanus toxoid vaccine market is advancing as thermostable technology eliminates cold-chain barriers that have historically limited distribution in tropical and remote regions. The Tetanus Toxoid Vaccine Market is projected to grow at 6.10% CAGR through 2035, with thermostable formulations representing a critical innovation for sub-Saharan Africa and South Asia. Current...